NCT03606317Active, not recruiting
Retrospective Review of Cachexia in Lung and Gastrointestinal Cancer Patients
Source: ClinicalTrials.gov · Last updated 21 Apr 2026
Brief summary (registry, in English)
The objective is to perform a retrospective chart review of patients with cachexia related to cancer in patients treated at UT Southwestern Medical Center and Parkland Hospital to evaluate the prognosis and practice patterns in management of cachexia and associated symptoms.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 20000 (estimated)
- First submitted
- 18 May 2018
- Start date
- 26 Nov 2013
- Primary completion date
- 18 Mar 2027
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Lung cancer
- NCT number
- NCT03606317
What you commit to
- Study type: Observational
- Planned participants: 20000
- From 26 Nov 2013 to the primary completion date, 18 Mar 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There will be no absolute exclusion criteria as long as the inclusion criteria have been met.
Who the study is looking for
- Medical charts representing patients with a diagnosis of lung or gastrointestinal cancer with a tissue diagnosis from 1/1/2005 and onward treated at UT Southwestern or Parkland.
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.